Tryp Therapeutics: Funding, Investors & Team (Sep 2026)
Tryp Therapeutics is a company that is concentrated on creating medications for rare diseases and diseases that have not been effectively treated. They primarily work on compounds that have established safety and efficacy profiles. One of their ventures is the PFN™ program, that concentrates on making synthetic psilocybin as a new kind of drug to cure particular neuropsychiatric-based maladies.
Tryp Therapeutics has raised $1.6M across 1 funding round on record, the most recent an undisclosed round of $1.6M announced in Apr 2023.
That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Tryp Therapeutics Company Profile and Key Stats
Latest funding round on record: Apr 2023.
Tryp Therapeutics Funding Rounds
Tryp Therapeutics Founders and Leadership Team
Contact details for the Tryp Therapeutics team: 1 of 1 has an email address on file.
Start 14-day free trial →Tryp Therapeutics Funding Compared to Other Biotechnology Startups
Tryp Therapeutics' latest round of $1.6M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Tryp Therapeutics in Biotechnology and Kelowna
Companies Similar to Tryp Therapeutics
Medicenna is a clinical-stage immunotherapy company focused on oncology and the development and…
Cybin is a clinical-stage biopharmaceutical company on a mission to create safe and effective…
Hemostemix Inc. is a Canadian biotechnology company that specializes in creating blood-derived cell therapies…
Avicanna is an organization in the biopharmaceutical sector that concentrates on enhancing medical cannabis…
Edesa Biotech is a privately-held company in the clinical stage that specializes in creating therapies for…
ME Therapeutics is a biotech company that specializes in finding and creating drugs for immuno-oncology that…
Aurinia Pharmaceuticals is a clinical stage biopharmaceutical company focused on developing and…
Medicus Pharma is a biotechnology research company that fast-tracks the progress of life sciences and…
ProteinQure is a biotechnology company specializing in creating innovative peptides for various medical…
Anodyne's mission is to create critical chemicals sustainably. Anodyne's approach takes advantage of nature's…
NervGen Pharma is a medicine company dedicated to creating solutions for the treatment of nerve damage and…
ZYUS is a biopharmaceutical company focused on providing patients with cannabinoids and other plant-based…
Tryp Therapeutics Funding FAQs
What does Tryp Therapeutics do?
Tryp Therapeutics is a company that is concentrated on creating medications for rare diseases and diseases that have not been effectively treated. They primarily work on compounds that have established safety and efficacy profiles. One of their ventures is the PFN™ program, that concentrates on making synthetic psilocybin as a new kind of drug to cure particular neuropsychiatric-based maladies.
How much funding has Tryp Therapeutics raised?
Tryp Therapeutics has raised $1.6M across 1 round on record. The most recent is an undisclosed round of $1.6M announced in Apr 2023.
When did Tryp Therapeutics last raise funding?
Tryp Therapeutics' most recent funding round on record is an undisclosed round of $1.6M, announced in Apr 2023.
Who is the CEO of Tryp Therapeutics?
James Gilligan is listed as CEO at Tryp Therapeutics.
Where is Tryp Therapeutics headquartered?
Tryp Therapeutics is based in Kelowna, British Columbia, Canada.
How many employees does Tryp Therapeutics have?
Tryp Therapeutics is in the 1-10 employee band.
How does Tryp Therapeutics' funding compare to other Biotechnology startups?
Tryp Therapeutics' latest round of $1.6M is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's Tryp Therapeutics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Tryp Therapeutics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.